Comment on: Bone Marrow Mesenchymal Stem Cells for Heart Failure Treatment: A Systematic Review and Meta-Analysis

We read with great interest the systematic review and meta-analysis by Kalou et  al. [1], published in this Journal, evaluating bone marrow mesenchymal stem cells (BM-MSCs) for heart failure treatment through a systematic review and meta-analysis by pooling six randomised clinical trials. The authors draw the conclusion that BM-MSCs treatment is an effective intervention for m anaging patients with heart failure, but requires larger and more robust clinical trials to support its routine use in clinics.
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: Letter to the Editor Source Type: research